Merit Medical Systems (MMSI) Projected to Post Quarterly Earnings on Tuesday

Merit Medical Systems (NASDAQ:MMSI) is anticipated to issue its quarterly earnings data after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.82 per share and revenue of $351.54 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Merit Medical Systems Trading Down 2.4 %

MMSI stock opened at $103.16 on Friday. Merit Medical Systems has a 1-year low of $70.70 and a 1-year high of $111.45. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82. The company has a market capitalization of $6.01 billion, a price-to-earnings ratio of 50.57, a PEG ratio of 2.34 and a beta of 0.87. The business has a 50 day simple moving average of $102.64 and a two-hundred day simple moving average of $99.57.

Analyst Ratings Changes

MMSI has been the subject of several recent analyst reports. Barrington Research upped their price target on Merit Medical Systems from $114.00 to $115.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 29th. Needham & Company LLC increased their target price on Merit Medical Systems from $109.00 to $122.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. Raymond James boosted their price target on shares of Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 31st. Robert W. Baird increased their price objective on shares of Merit Medical Systems from $107.00 to $109.00 and gave the company an “outperform” rating in a research report on Thursday, October 31st. Finally, Piper Sandler reissued an “overweight” rating and issued a $116.00 price objective (up from $114.00) on shares of Merit Medical Systems in a research note on Wednesday, January 29th. Two equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $109.80.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.